By expenditures
| Name | Title | Type |
|---|---|---|
| Tina Jaster | Executive Director | Auditee |
| Vicki Leaderbrand | EXECUTIVE DIRECTOR | Auditee |
| Bill MacFarlane | Accounting Manager | Auditee |
| Marie Primus | Partner | Auditee |
| John Hemming | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 330594 | 2024 | 2024-12-03 | Bergankdv LTD | $7.84M |
| 15024 | 2023 | 2024-02-01 | Bergankdv LTD | $7.95M |
| 39319 | 2022 | 2023-01-10 | Wipfli LLP | $7.94M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 330594 | 2024 | 2024-12-03 | 1089290 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089289 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089288 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089287 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089286 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089285 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089284 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089283 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089282 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 1089281 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512848 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512847 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512846 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512845 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512844 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512843 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512842 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512841 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512840 | 2024-002 | Significant Deficiency | - | L |
| 330594 | 2024 | 2024-12-03 | 512839 | 2024-002 | Significant Deficiency | - | L |
| 15024 | 2023 | 2024-02-01 | 587681 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 587680 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 587679 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 587678 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 587677 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 587676 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 587675 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 587674 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11239 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11238 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11237 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11236 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11235 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11234 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11233 | 2023-003 | Significant Deficiency | - | AB |
| 15024 | 2023 | 2024-02-01 | 11232 | 2023-003 | Significant Deficiency | - | AB |